NCT00929006View on ClinicalTrials.gov

Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
PubertyHyperandrogenism
Interventions
DRUG

Micronized progesterone suspension

Micronized progesterone 0.8 mg/kg at 0700, 1500, 2300 and 0700 h. Progesterone is a natural hormone.

DRUG

Placebo

Placebo contains only inert ingredients and is not expected to exert any direct physiological effects

Trial Locations (1)

22908

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Virginia

OTHER